Repligen Corporation (RGEN)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 41,577 115,794 138,027 167,824 185,959 166,340 159,433 145,805 128,291 118,879 99,933 79,561 59,926 43,832 30,939 23,173 21,411 23,445 26,580 21,223
Total stockholders’ equity US$ in thousands 1,971,200 1,988,560 1,970,930 1,940,490 1,910,700 1,835,110 1,805,360 1,766,400 1,750,070 1,715,260 1,603,070 1,556,220 1,529,150 1,124,870 1,100,030 1,069,760 1,059,770 1,045,120 878,968 625,025
ROE 2.11% 5.82% 7.00% 8.65% 9.73% 9.06% 8.83% 8.25% 7.33% 6.93% 6.23% 5.11% 3.92% 3.90% 2.81% 2.17% 2.02% 2.24% 3.02% 3.40%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $41,577K ÷ $1,971,200K
= 2.11%

Repligen Corp.'s return on equity (ROE) has shown some fluctuations over the past eight quarters. The ROE ranged from a low of 2.11% in Q4 2023 to a high of 9.73% in Q4 2022. The downward trend in ROE from Q4 2022 to Q4 2023 indicates a decline in the company's ability to generate profit from shareholder equity during this period. The decreasing trend suggests that the company may be experiencing challenges in efficiently utilizing its equity to generate profits, which could raise concerns about its overall financial performance. The management should closely monitor and assess the factors contributing to this trend and take appropriate measures to improve the ROE in the future quarters.


Peer comparison

Dec 31, 2023